One Obstacle to Curing Cancer: Patient Data Isn’t Shared
NOVEMBER 28, 2016
The development of targeted therapies and immunotherapies — the two biggest hopes for cancer cures — depend on the existence of large data sets comprising patients’ genetic and clinical information. Only after this can the scientists begin their work of developing targeted therapies to overcome the effects of the mutated genes. Let’s begin with the academic medical centers, which are the most likely to collect genetic information on their patients.